About Us
Firefly Innovations LLC, creates highly antimicrobial, environmentally friendly, and patented antimicrobial and 3D printing technologies derived from nature.
Our mission is to advance the wound care market and address the unmet needs of patients through eco-friendly alternatives to silver dressing.
Our patented antimicrobial technology platform disrupts the current standard of care for treating wounds in the inflammatory phase:
-
More effective (2 logs) at disrupting biofilms than silver
-
Derived from natural ingredients to address the growing concerns raised by silver dressing waste
-
Absorbs the characteristic odor of chronic wounds, improving the comfort of patients and caregivers
Our 3D printing technology aims at improving dressing ease of use with better tensile strength, fluid management, and mechanical action than the standard of care.
Firefly Innovations, LLC addresses a $1.5 billion market with several unmet needs
All wounds undergo 4 common stages of wound healing:
4
Remodeling
Freshly healed epidermis
Freshly
healed
dermis
2
Scab
Inflammation
Fibroblast
Macrophage
Blood vessel
Bacterial infections maintain wounds in the inflammation phase and prevent the wound healing process. They have to be treated locally by antimicrobial dressing.
3
Proliferation
Proliferating
Fibroblast
Subcutaneous fat
1
Hemostasis
Blood Clot
Every year 6.5 million people suffer from chronic wounds in the U.S.
Annual cost to the U.S. healthcare
system from chronic wounds
$28B
Global antimicrobial dressing
market size and split by technology
SILVER
OTHERS
70%
30%
$1.5B
Antimicrobial Market Size, Global, 2018
Unmet needs
by current antimicrobial dressings
They are typically not efficient at treating bacterial biofilms or require a high dose of antimicrobial agents in order to be effective.
They can prevent wound healing by destroying healthy tissues and/or preventing cell proliferation and migration.
The waste from silver dressings is harmful to the environment and raise environmental concerns particularly in the EU.
